TCR2 Therapeutics Inc. (TCRR) Financial Statements
TCR2 Therapeutics Inc. (TCRR) files with the U.S. Securities and Exchange Commission under CIK 0001750019. 10KGenie shows its annual and quarterly statements from SEC filings.
Key Figures, Fiscal Year 2022
- Net Income
- -$151.82 million
- Total Assets
- $208.24 million
- Net Cash from Operations
- -$101.46 million
Fiscal year ended Dec 31, 2022. Latest periodic SEC filing: May 11, 2023. Source: SEC filings (EDGAR XBRL).
Open the full financial statements for TCRR in 10KGenie
Data from SEC EDGAR filings. 10KGenie is not affiliated with the SEC. SEC Filing History